Duopharma Biotech eyes more halal exports to Indonesia


KLANG: Duopharma Biotech Bhd has anticipated higher halal pharmaceuticals demand from Indonesia in the near term under its export expansion plan.

Its group managing director Leonard Ariff Abdul Shatar said Indonesia is moving towards implementing a law, originally slated for 2022 or 2023, that mandates halal certification for over-the-counter pharmaceutical products.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

VS Industry reports 2Q net loss
GuocoLand to table RM1.10-per-share privatisation proposal at EGM
Ringgit weakens against US dollar, other currencies�amid West Asia war
Axis-REIT aborts proposed acquisition of RM800mil industrial property
Kim Loong reports higher 4Q net profit
YTL REIT leases AC Hotel Puchong to YTL Corp unit
Binastra to sustain growth momentum
SC launches FIKRALab to drive development of Islamic capital market products
FBM KLCI ends at day’s low, ringgit hits two-month low
Gold drops 1% as markets assess Mideast ceasefire prospects

Others Also Read